Sign In
Home
Abiraterone - Abiraterone Acetate tablet
Get your patient on
Abiraterone - Abiraterone Acetate tablet
(Abiraterone Acetate)
oral pill - 250 mg tab
Check coverage
See the specific documentation and step therapies required.
Check coverage
Medication interactions
See all drug-to-drug interactions for this medication.
Check interactions
Prescribing info
PubMed™ news
Abiraterone - Abiraterone Acetate tablet prescribing information
Data source
Data source
Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
Report Adverse Event
Check medication interactions
Review interactions as part of your prescribing workflow
Check interactions
Abiraterone - Abiraterone Acetate tablet PubMed™ news
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
5 most recent articles for Abiraterone - Abiraterone Acetate tablet
,
view all articles on PubMed™
Journal Article • 2026 May
A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer.
Journal Article • 2026 May
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.
Journal Article • 2026 May
Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial.
Journal Article • 2026 May
Phase III randomized studies of mevrometostat and enzalutamide in metastatic prostate cancer (MEVPRO-1 and MEVPRO-2): trial protocols.
Journal Article • 2026 May
Integrated in silico investigation of an androstendiol derivative (monoxetanol) as a potential anti-prostate cancer agent: insights from molecular docking, MD simulations, MM/PBSA, ADMET, and DFT analyses.
Show the latest PubMed™ articles for Abiraterone - Abiraterone Acetate tablet
I certify that I'm a U.S. healthcare provider
